ES327925A1 - A procedure for the production of hydrogenated derivatives of tebaina and oripavina. (Machine-translation by Google Translate, not legally binding) - Google Patents

A procedure for the production of hydrogenated derivatives of tebaina and oripavina. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES327925A1
ES327925A1 ES0327925A ES327925A ES327925A1 ES 327925 A1 ES327925 A1 ES 327925A1 ES 0327925 A ES0327925 A ES 0327925A ES 327925 A ES327925 A ES 327925A ES 327925 A1 ES327925 A1 ES 327925A1
Authority
ES
Spain
Prior art keywords
group
carbon atoms
hydrogen atom
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0327925A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rectitt And Sons Ltd
Original Assignee
Rectitt And Sons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rectitt And Sons Ltd filed Critical Rectitt And Sons Ltd
Publication of ES327925A1 publication Critical patent/ES327925A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for the production of hydrogenated derivatives of thebaine and oripavine which are compounds of the formula: ** (See formula) ** where R represents a hydrogen atom, a methyl group, the group CnH2n + 1Co-, where n is an integer from 1 to 3 inclusive, benzoyl or nicotinyl; R1 represents a hydrogen atom, an alkyl, alkenyl or alkynyl group containing up to 8 carbon atoms, or an alicyclicly substituted methyl group in which the total number of carbon atoms is from 4 to 8; R 2 represents a hydrogen atom, an alkyl or alkenyl group containing up to 3 carbon atoms, an aryl group or a substituted aryl group; R3 represents a hydrogen atom, an alicyclic group containing from 4 to 8 carbon atoms, an alkyl, alkenyl or alkynyl group containing up to 8 carbon atoms, which may be substituted on carbon atoms numbers 1 to 4 (the carbon atoms # 1 are adjacent to the carbon atom bearing the alcoholic hydroxyl group) by an alicyclic, aryl, alkoxy, aryloxy or hetercyclic group containing oxygen provided that when R represents a hydrogen atom, R3 and R4 do not contain the -CH-aryl and -CH-C = C- systems attached directly to the carbon atom bearing the alcoholic hydroxyl group; whose process consists in hydrogenating, in the presence of a hydrogenation catalyst, (a) a compound of the formula: ** (See formula) ** where R1, R2 and R3 have the meaning given above, or (b) a compound of formula: ** (See formula) ** wherein R1 and R2 have the meaning given above, and reacting the hydrogenated product with an organometallic derivative, such as a Grignard reagent or an organolytic compound, in which the R3 group is attached to a metal atom, or (c) a compound of formula: ** (See formula) ** where ALK represents an alkyl radical, and reducing the hydrogenated product with lithium aluminum hydride to give a product in which R2 and R3 both represent a hydrogen atom and, at will, replace the radicals R and R1 with others of the same group , after stages (a), (b) or (c). (Machine-translation by Google Translate, not legally binding)
ES0327925A 1965-06-15 1966-06-14 A procedure for the production of hydrogenated derivatives of tebaina and oripavina. (Machine-translation by Google Translate, not legally binding) Expired ES327925A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
ES327925A1 true ES327925A1 (en) 1967-04-01

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0327925A Expired ES327925A1 (en) 1965-06-15 1966-06-14 A procedure for the production of hydrogenated derivatives of tebaina and oripavina. (Machine-translation by Google Translate, not legally binding)

Country Status (14)

Country Link
AT (1) AT272530B (en)
BE (1) BE682551A (en)
BR (1) BR6680359D0 (en)
CH (1) CH558362A (en)
DE (1) DE1620206A1 (en)
DK (1) DK115926B (en)
ES (1) ES327925A1 (en)
FI (1) FI49724C (en)
FR (1) FR6395M (en)
GB (1) GB1136214A (en)
LU (1) LU51306A1 (en)
NL (1) NL6608255A (en)
NO (1) NO119590B (en)
SE (1) SE325276B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (en) * 1983-11-16 1986-09-26 Sanofi Sa NEW NORORIPAVIN DERIVATIVE HAVING BOTH AGONIST AND ANTAGONIST ACTIVITY OF MORPHINIC RECEPTORS
KR100204659B1 (en) * 1996-05-28 1999-06-15 강재헌 A novel analgesic compounds having buprenorphine structure
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
CA2614223A1 (en) 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
DE102006054731B4 (en) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for administration of the active ingredient buprenorphine and use thereof in pain therapy
EP2703404A1 (en) 2008-07-30 2014-03-05 Purdue Pharma L.P. Buprenorphine analogs
WO2010039216A1 (en) * 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the alkylation of norbuprenorphine with reduced impurity formation
WO2010121369A1 (en) 2009-04-24 2010-10-28 Brock University Processes for the preparation of morphinane and morphinone compounds
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
AR089201A1 (en) 2011-12-12 2014-08-06 Lohmann Therapie Syst Lts TRANSDERMAL SUPPLY SYSTEM
RS61377B1 (en) 2012-07-26 2021-02-26 Camurus Ab Opioid formulations
US9175000B2 (en) * 2012-12-07 2015-11-03 Purdue Pharma L.P. Buprenorphine analogs
PT2810646T (en) 2013-06-04 2016-10-05 Lts Lohmann Therapie Systeme Ag Transdermal delivery system
CA3238849A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Also Published As

Publication number Publication date
DK115926B (en) 1969-11-24
NO119590B (en) 1970-06-08
SE325276B (en) 1970-06-29
CH558362A (en) 1975-01-31
BE682551A (en) 1966-11-14
DE1620206A1 (en) 1970-03-19
NL6608255A (en) 1966-12-16
BR6680359D0 (en) 1973-12-26
GB1136214A (en) 1968-12-11
FI49724C (en) 1975-09-10
FR6395M (en) 1968-10-21
LU51306A1 (en) 1966-08-16
FI49724B (en) 1975-06-02
AT272530B (en) 1969-07-10

Similar Documents

Publication Publication Date Title
ES327925A1 (en) A procedure for the production of hydrogenated derivatives of tebaina and oripavina. (Machine-translation by Google Translate, not legally binding)
ES296197A1 (en) A procedure for preparing N-vinil - 2 - imidazolines (Machine-translation by Google Translate, not legally binding)
ES358689A1 (en) Process for making 2-benzimidazolecarbamic acid alkyl esters
ES400841A1 (en) 2-hydroxybenzophenones
ES382984A1 (en) 4-chloropyrazolyl compounds
ES412047A1 (en) Preparation of dihydrocoumarin and of alkyl derivatives thereof
ES327203A1 (en) Procedure for the production of benzo-diacepin-8-ona derivatives. (Machine-translation by Google Translate, not legally binding)
ES373998A1 (en) Procedure for the production of orthosethyled feniletilaminas. (Machine-translation by Google Translate, not legally binding)
ES415477A1 (en) A procedure for preparing benzocicloheptaisoquinoleinas. (Machine-translation by Google Translate, not legally binding)
ES437041A1 (en) A procedure for preparing 1-ftalazone derivatives. (Machine-translation by Google Translate, not legally binding)
ES324040A1 (en) Procedure for the production of derivatives of sulfonamidoquinazolina. (Machine-translation by Google Translate, not legally binding)
ES241076A1 (en) New procedure for the obtaining of piperacine derivatives. (Machine-translation by Google Translate, not legally binding)
ES364724A1 (en) Procedure for the preparation of new derivatives of paminoalquil-bencensulfonamida. (Machine-translation by Google Translate, not legally binding)
ES434355A1 (en) Device to vary the width of via, especially of agricultural vehicles. (Machine-translation by Google Translate, not legally binding)
ES226163A1 (en) A procedure for the preparation of piperidine derivatives (Machine-translation by Google Translate, not legally binding)
ES399518A1 (en) Imidocarbonates processes for producing them and compositions containing them
ES287028A1 (en) Procedure for the manufacture of new basic derivatives of fenoxazine and its salts (Machine-translation by Google Translate, not legally binding)
ES307303A1 (en) A procedure for the preparation of an amine. (Machine-translation by Google Translate, not legally binding)
ES315451A1 (en) Procedure for preparation of tetrahydrofuran derivatives. (Machine-translation by Google Translate, not legally binding)
ES231810A1 (en) A procedure for the preparation of acil-anylides with basic substitutors and their derivatives (Machine-translation by Google Translate, not legally binding)
ES334733A1 (en) Procedure for preparing derivatives of acid esters-5halobenzoicos. (Machine-translation by Google Translate, not legally binding)
ES325366A1 (en) Procedure for the production of derivatives of isoquinoline. (Machine-translation by Google Translate, not legally binding)
ES351078A3 (en) A procedure for preparing cyclopentanopolyhydrophenanthrene derivatives. (Machine-translation by Google Translate, not legally binding)
ES307914A1 (en) A method of preparing cyclated derivatives of 0-carboxibencenosulfonico acid. (Machine-translation by Google Translate, not legally binding)
ES332627A1 (en) Procedure for the preparation of derivatives of fenotiazine. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19870112